FDA Approved Products

6,646 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

NOVRAD
levopropoxyphene napsylate anhydrous
LOE Approaching
Eli Lilly and Company
ORAL · CAPSULE
1962
NDA
30/100
NOXAFIL
posaconazole
LOE Approaching
Merck & Co.
ORAL · SUSPENSION
2006
SMNDA
30/100
NOXAFIL
posaconazole
LOE Approaching
Merck & Co.
ORAL · SUSPENSION
invasive aspergillosisolder+11
2006
SMNDA
30/100
NOXAFIL POWDERMIX KIT
posaconazole
Peak
Merck & Co.
ORAL · FOR SUSPENSION, DELAYED RELEASE
invasive aspergillosisolder+11
2021
SMNDA
30/100
NUBAIN
nalbuphine hydrochloride
LOE Approaching
Pfizer
INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS · SOLUTION
1979
NDA
30/100
NULYTELY
polyethylene glycol 3350, sodium chloride, sodium bicarbonate, potassium chloride
LOE Approaching
R-Pharm US
ORAL · FOR SOLUTION
1991
NDA
30/100
NULYTELY-FLAVORED
polyethylene glycol 3350, sodium chloride, sodium bicarbonate, potassium chloride
LOE Approaching
R-Pharm US
ORAL · FOR SOLUTION
1991
NDA
30/100
NUMORPHAN
oxymorphone hydrochloride
LOE Approaching
RECTAL · SUPPOSITORY
1960
NDA
30/100
NUPRIN
ibuprofen
LOE Approaching
ORAL · TABLET
1984
SMNDA
30/100
NUROMAX
doxacurium chloride
LOE Approaching
AbbVie
INJECTION · INJECTABLE
1991
NDA
30/100
NUTRESTORE
l-glutamine
LOE Approaching
Emmaus Life Sciences
ORAL · FOR SOLUTION
2004
NDA
30/100
NUTRILIPID 10%
soybean oil
LOE Approaching
B. Braun
INJECTION · INJECTABLE
1993
NDA
30/100
NUTRILIPID 20%
soybean oil
LOE Approaching
B. Braun
INJECTION · INJECTABLE
1993
NDA
30/100
NUVARING
etonogestrel and ethinyl estradiol
LOE Approaching
Merck & Co.
VAGINAL · RING
2001
NDA
30/100
NUVIGIL
armodafinil
LOE Approaching
ORAL · TABLET
excessive sleepinesswakefulness in adult patients with excessive sleepiness associated with obstructive sleep apnea (OSA)+2
2007
NDA
30/100
NYDRAZID
isoniazid
LOE Approaching
Novartis
INJECTION · INJECTABLE
1952
NDA
30/100
Nitrogen, NF
nitrogen
Peak
Advanced Solutions Life Sciences
INHALATION · GAS
2020
NDA
30/100
Nitrogen, NF
nitrogen
Peak
INHALATION · GAS
2022
NDA
30/100
OCL
polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate
LOE Approaching
Pfizer
ORAL · SOLUTION
1986
NDA
30/100
OCTREOSCAN
indium in -111 pentetreotide
LOE Approaching
Curium Pharma
INJECTION · INJECTABLE
1994
PeptideNDA
30/100
OCUCLEAR
oxymetazoline hydrochloride
LOE Approaching
Bayer
OPHTHALMIC · SOLUTION/DROPS
1986
NDA
30/100
OCUFEN
flurbiprofen sodium
LOE Approaching
AbbVie
OPHTHALMIC · SOLUTION/DROPS
1986
NDA
30/100
OCUFLOX
ofloxacin
LOE Approaching
AbbVie
OPHTHALMIC · SOLUTION/DROPS
1993
SMNDA
30/100
OCUPRESS
carteolol hydrochloride
LOE Approaching
Novartis
OPHTHALMIC · SOLUTION/DROPS
1990
NDA
30/100
← PreviousPage 124 of 277Next →